Sort   by:  
 Page size 
UnknownResults of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma.
Not available
S-EPMC3646316 | biostudies-literature
UnknownUpdated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma.
Not available
S-EPMC4439262 | biostudies-literature
UnknownBleeding and recurrent VTE with apixaban vs warfarin as outpatient treatment: time-course and subgroup analyses.
Not available
S-EPMC6988406 | biostudies-literature
UnknownFive-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.
Not available
S-EPMC5746164 | biostudies-literature
UnknownMUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.
Not available
S-EPMC3936405 | biostudies-literature
UnknownVaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.
Not available
S-EPMC3755905 | biostudies-literature
UnknownIndividualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.
Not available
S-EPMC5800949 | biostudies-literature
UnknownProvider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma.
Not available
S-EPMC8174017 | biostudies-literature
UnknownDepressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease.
Not available
S-EPMC3806339 | biostudies-literature
UnknownPrediction of disability-free survival in healthy older people.
Not available
S-EPMC9213595 | biostudies-literature
Sort   by:  
 Page size